Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week open label, long-term safety extension study of CAM2038 in patients with chronic non-cancer pain

Next Previous
Trial Profile

A 52-week open label, long-term safety extension study of CAM2038 in patients with chronic non-cancer pain

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 16 May 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 09 May 2019 According to a Camurus media release, the last patients has completed their treatment during the first quarter of 2019. After closing of the database and compiling the results from this study , the company will meet with European regulatory authorities to discuss the regulatory submission for CAM2038 for the treatment of chronic pain. The company plan to submit in the EU during the first half of 2020.
  • 09 May 2019 Status changed from recruiting to active, no longer recruiting, according to a Camurus media release.
  • 05 Feb 2019 According to a Camurus media release, long-term safety results are expected in the second quarter 2019.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top